Center-Authored Papers

Filters: Author is Parsons, J Kellogg  [Clear All Filters]
2016
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB et al..  2016.  NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(5):509-19. Abstract
2015
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI et al..  2015.  Prostate Cancer Early Detection, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(12):1534-61. Abstract
2012
Parsons KJ, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, Kristal AR.  2012.  Finasteride Reduces the Risk of Incident Clinical Benign Prostatic Hyperplasia.. European urology. Abstract
Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons KJ, Thompson IM, Kristal AR.  2012.  Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 176(2):156-63. Abstract
2011
Klein EA, Thompson IM, Tangen CM, Crowley J, Lucia SM, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano MJ et al..  2011.  Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 306(14):1549-56. Abstract
2009
Lippman SM, Klein EA, Goodman PJ, Lucia SM, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano MJ, Hartline JA et al..  2009.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).. JAMA : the journal of the American Medical Association. 301(1):39-51. Abstract